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profile in various animal models; therefore, we hypothesized that açaí pulp (Euterpe oleracea
Mart.) maymodulate the expression of the genes involved in cholesterol homeostasis in the
liver and increase fecal excretion, thus reducing serum cholesterol. To test this hypothesis,
we analyzed the expression of 7α-hydroxylase and ATP-binding cassette, subfamily G
transporters (ABCG5 and ABCG8), which are genes involved with the secretion of cholesterol
in the rat. We also evaluated the expression of sterol regulatory element–binding protein 2,
3-hydroxy-3-methylglutaryl CoA reductase, low-density lipoprotein receptor (LDL-R), and
apolipoprotein B100, which are involved in cholesterol biosynthesis. Female Fischer rats
were divided into 4 groups: the C group, which was fed a standard AIN-93 M diet; the CA
group, which was fed a standard diet supplemented with 2% açaí pulp; the H group, which
was fed a hypercholesterolemic diet (25% soy oil and 1% cholesterol); and the HA group,
which was fed a hypercholesterolemic diet supplemented with 2% açaí pulp. At the end of
the experimental period, the rats were euthanized, and their blood and livers were collected.
The HA group exhibited a significant decrease in serum total cholesterol, low-density
lipoprotein cholesterol, and atherogenic index and also had increased high-density
lipoprotein cholesterol and cholesterol excretion in feces compared with the H group. In
addition, the expression of the LDL-R, ABCG5, and ABCG8 genes was significantly increased
by the presence of açaí pulp. These results suggest that açaí pulp promotes aKeywords:
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through an increase in the expression of ATP-binding cassette, subfamily G transporters,
and LDL-R genes.
© 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
The açaí is the fruit of the Euterpe oleracea Martius tree, a
species that is currently among the most economically
significant palm species in the Brazilian Amazon region.
This fruit has become one of themain products of the Amazon
estuary and is exported to other regions of the world [1]. The
açaí is a rounded fruit andweighs approximately 2 g. Only 17%
(pulp with peel) of the fruit is edible because the seed
comprises the remaining inedible portion. The color of the
mature fruit is purple to nearly black. Açaí gained popularity
in North America after being promoted as a “Superfood for
Age-Defying Beauty” [2]. It contains approximately 13%
protein, 48% lipids, and 1.5% total sugar. It is rich in phenolic
compounds (mainly anthocyanins), monounsaturated and
polyunsaturated fatty acids, phytosterols (eg, β-sitosterol),
and dietary fiber, in addition to being a good source of
potassium, magnesium, calcium, phosphorus, sodium, and
vitamins E and B1 [3-5].
There are studies reporting on the antioxidant and anti-
inflammatory activities of açaí because it presents high
antioxidant capacity in vitro [6,7], antioxidant potential in
vivo [8-11], anti-inflammatory properties [12,13], and proa-
poptotic and antiproliferative activities against HL-60 leuke-
mia cancer cells [14].
Furthermore, studies have demonstrated that açaí pro-
motes an improvement in the markers of metabolic disease
risk. Elevated levels of total and non–high-density lipoprotein
(HDL) cholesterol (HDL-C) in the serum and the atherogenic
index of rats fed a hypercholesterolemic diet were reduced
after diet supplementation with açaí pulp [15]. Supplementa-
tion of 2% açaí in food increased the lifespan of sod1 RNAi
female flies that were fed a high-fat diet compared with
nonsupplemented control flies. Furthermore, açaí adminis-
tration decreased the transcript level of phosphoenol-pyru-
vate carboxykinase (Pepck), a key enzyme controlling
gluconeogenesis [16]. The long-term administration of açaí
seed extract protected C57BL/6J mice fed a high-fat diet that
was designed to promote the phenotypic and metabolic
characteristics of metabolic syndrome [17]. Açaí juice had
atheroprotective effects in hyperlipidemic apolipoprotein E–
deficient mice fed a high-fat diet [11] and markedly improved
the lipid profile and attenuated atherosclerosis in New
Zealand rabbits fed a cholesterol-enriched diet [18]. The
cited studies demonstrate that the consumption of açaí
improves serum lipid profile and can exert an atheroprotec-
tive effect; however, it is not knownwhether açaí interferes in
hepatic cholesterol metabolism.
The liver plays a key role in cholesterol homeostasis
because it controls the supply and removal pathways.
Cholesterol biosynthesis is partially governed at the tran-
scriptional level by sterol regulatory element–binding protein
2 (SREBP-2) [19]. When cells are deprived of cholesterol, theSREBPs embedded in the membranes of the endoplasmic
reticulum are cleaved, enter the nucleus, and bind to the
promoters of key genes involved in cholesterol homeostasis.
Thus, cleavage activation of SREBP results in increased low-
density lipoprotein receptor (LDL-R)–mediated plasma cho-
lesterol uptake and increased cholesterol biosynthesis, in
which 3-hydroxy-3-methylglutaryl CoA reductase (HMG CoA-
R) is a rate-limiting enzyme. Both the LDL-R and HMG CoA-R
genes have a sterol regulatory element in their promoter
regions and are commonly regulated by SREBP-2 [20-22]. In
contrast, the liver eliminates excess cholesterol from the body
either by direct secretion into the bile or after its conversion
into bile acids via an enzymatic pathway governed by the rate-
limiting enzyme cholesterol 7α-hydroxylase (CYP7A1) [23,24].
In addition, the ATP-binding cassette, subfamily G trans-
porters (ABCG), ABCG5 and ABCG8, play a significant role in
the direct excretion of cholesterol via the bile [25].
In this study, we hypothesized that because of its
phytochemical and nutrient components, açaí pulp may
modulate the expression of genes involved in cholesterol
homeostasis in the liver and increase fecal excretion, thus
leading to a reduction of serum cholesterol. Rats fed a diet rich
in lipids were used because they develop hypercholesterol-
emia and liver lipid accumulation [15,26-28]. The present
study was undertaken to characterize the effect of açaí pulp
on the expression of the genes involved in cholesterol
homeostasis in the liver. Owing to their roles in cholesterol
biosynthesis, the expression of SREBP-2, HMG CoA-R, LDL-R,
and apolipoprotein B100 (ApoB100) was analyzed. To evaluate
the proteins involved in the elimination of excess cholesterol
from the body, the expression of CYP7A1, ABCG5, and ABCG8
was also investigated. In addition, we investigated the effect
of dietary supplementation with açaí pulp on the fecal
excretion of cholesterol in rats.2. Methods and materials
2.1. Açaí pulp
Pasteurized açaí (E oleracea Martius) pulp was obtained from
Icefruit Comercio de Alimentos Ltd. (Tatuí, São Paulo, Brazil).
This pulp contained no preservatives or artificial coloring and
was pasteurized, vacuum packed, and stored at −18°C. The
moisture content was 90%. Each 100 g of dry weight contained
42 g of total fat, 7.0 g of protein, 1.1 g of sugar, and 43 g of fiber,
as determined by the Instituto Adolfo Lutz (2008) [29].
2.2. Animals
Nine-week-old female Fischer rats weighing approximately
140 g were obtained from the Experimental Nutrition Labora-
tory of the Federal University of Ouro Preto. The animals were
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maintained in a room with controlled conditions (24°C, 55%
humidity, 12-hour light/dark cycles), and food and water were
provided ad libitum. The animal experimental procedures
were approved by the Ethics Committee on Animal Use of the
Federal University of Ouro Preto (no. 2010/23).
2.3. Diets and experimental design
The rats were randomly divided into 4 experimental groups
of 8 animals each, balanced for weight. The first group served
as the control (C) and received a standard AIN-93 M diet [30],
the second group (H) received a hypercholesterolemic diet
(25% soy oil and 1% cholesterol), the third group (CA) received
the same standard diet supplemented with 2% açaí (dry wt/
wt), and the fourth group (HA) received the same hypercho-
lesterolemic diet supplemented with 2% açaí (dry wt/wt). The
diet composition for each group is presented in Table 1.
While in the metabolic cages, for 2 weeks before the 6-week
experimental period, the C and CA groups received the
standard diet and the H and HA groups received the
hypercholesterolemic diet [15]. The food consumption of
the animals was measured daily and was corrected for
spillage. The feces were collected daily, and the body weight
of the animals was recorded weekly.
2.4. Sample preparation
After fasting for 12 hours, blood (0.5 mL) was collected from
the retro-orbital sinus into a heparinized capillary tube under
light anesthesia with isoflurane (Cristália, Itapira, SP, Brazil).
This was collected at the beginning of the experiment and
at the end of the second week of adaptation to ensure
uniformity in the concentration of total cholesterol (TC)
among animals. The sampled blood was centrifuged at
1500 × g for 15 minutes, and the plasma was collected and
stored at −20°C until TC analysis.Table 1 – Ingredient composition (in grams per kilogram) and e
Nutrients Standard diet Standard die
plus açaí
Caseina 140.0 140.0
Corn starch 722.5 702.5
Soybean oil b 40.0 40.0
Cholesterol c 0.0 0.0
Choline 2.5 2.5
Mineral mixture d 35.0 35.0
Vitamin mixture e 10.0 10.0
Cellulose 50.0 50.0
Açaí pulp f 0.0 20.0
Energy content g (kcal/kg) 3810 3812
a Isofar (Duque de Caxias, Rio de Janeiro, Brazil), containing 85% protein
b Brasil Foods SA (São Paulo, Brazil).
c Vetec Química Fina Ltd (Duque de Caxias, Rio de Janeiro, Brazil).
d Mineral mixture as recommended by the AIN-93M rodent diet [30].
e Vitamin mixture as recommended by the AIN-93M rodent diet [30].
f Açaí pulp energy content: 82 kcal/20 g.
g Conversion factors: protein, 4 kcal/g; fat, 9 kcal/g; sugars, 4 kcal/g.At the end of the experimental period, the rats were fasted
for 12 hours, anesthetized with isoflurane (Cristália), and
euthanized by total blood collection from the brachial plexus.
To determine the serum component levels, blood samples
were collected in 5-mL test tubes and centrifuged at 1500 × g
for 15 minutes. The animal livers were collected, washed in
saline, weighed, immersed in liquid nitrogen, and immedi-
ately stored at −80°C for subsequent analysis. The feces were
removed from the cecum, dried in a ventilated oven at 60°C,
ground, weighed, and stored at −80°C for subsequent analysis.
2.5. Cholesterol analysis in serum and feces
Serum TC was measured with an enzymatic colorimetric Lab
Test Kit No. 60-2/100 (Labtest Diagnostic, Lagoa Santa, MG,
Brazil), with cholesterol standards as appropriate. After the
precipitation of LDL and very low-density lipoprotein (VLDL)
with phosphotungstic acid/MgCl2, the HDL-C level in the
supernatant was evaluated using a Lab Test Kit No. 13 (Labtest
Diagnostic, Lagoa Santa, MG, Brazil). The non–HDL-C level was
calculated as the difference between the TC and HDL-C levels
[31]. Non–HDL-C represents all potentially atherogenic lipo-
proteins, that is, LDL and VLDL. The atherogenic index was
obtained from the non–HDL-C/HDL-C ratio.
The total fecal fat was extracted with a chloroform/
methanol mixture (2:1, vol/vol) (Vetec Química Fina Ltd,
Duque de Caxias, RJ, Brazil), according to the method of
Folch et al [32]. The total lipid fecal matter was obtained by
evaporating the solvents in the extract, and then the TC was
measured using a commercial Lab Test Kit No. 60-2/100
(Labtest Diagnostic).
2.6. Quantitative real-time reverse transcriptase
polymerase chain reaction assay
The total RNAwas isolated from the liver tissue of rats using the
RNAgents Total RNA Isolation System (Promega Corporation,nergy content of the diets fed to rats
t Hypercholesterolemic
diet
Hypercholesterolemic
diet plus açaí
140.0 140.0
502.5 482.5
250.0 250.0
10.0 10.0
2.5 2.5
35.0 35.0
10.0 10.0
50.0 50.0
0.0 20.0
4820 4822
.
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tions. The concentration and purity of the RNA were estimated
spectrophotometrically using the A260/A280 ratio (NanoVue; GE
Healthcare, Hertfordshere, UK). Complementary DNA (cDNA)
was synthesized from 2 μg of total RNA with random primers
using a High-Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Foster City, CA, USA) and following the manufac-
turer's recommendations. Quantitative real-time polymerase
chain reaction (PCR) was performed using a SYBR Green PCR
Master Mix reagent (Applied Biosystems) in a final reaction
volumeof 12 μL. The reaction included 2 μL of cDNAand0.5 μL of
each primer (forward and reverse, 10 μM). The forward and
reverse primer sequences for SREBP-2 and CYP7A1 were
obtained from published nucleotide sequences [33], as were
those for ABCG5 and ABCG8 [34]. The primer sequences for
ApoB100 (forward primer 5-AGTAGTGGTGCGTCTTGGATCCA-3′
and reverse primer 5-ACTCTGCAGCAAGCTGTTGAATGT-3′)
were derived from theRattus norvegicus genome (National Center
for Biotechnology Information GenBank, accession number
NM_019287) and were constructed using the Primer-BLAST
Program (http://www.ncbi.nlm.nih.gov/tools/primer-blast/).
The forward and reverse primer sequences for LDL-R and HMG
CoA-Rwere obtained from published nucleotide sequences [35],
as were those for glyceraldehyde-3-phosphate dehydrogenase
[36]. All primers were synthesized by Invitrogen Life Technolo-
gies (São Paulo, Brazil). The reactions were performed using an
ABI Prism 7000 Sequence Detector (Applied Biosystems) under
the following conditions: 50°C for 2minutes, 95°C for 10minutes,
and 40 cycles of 95°C for 15 seconds, and 60°C for 1 minute. The
specificity of the products obtainedwas confirmed by analyzing
the dissociation curves of the amplified product. As an internal
control, the expression of the endogenous glyceraldehyde-3-
phosphate dehydrogenase gene was used. The data obtained
were analyzed using the comparative cycle threshold method.
All analyses were performed in triplicate.
2.7. Statistical analyses
The normality of the data was tested using the Kolmogorov-
Smirnov test. Data (Tables 2, 3, and 4) consistent with a normal
distribution were subjected to 2-way analysis of variance in
which the classification factors were diet (C + CA × H + HA), açaí
(CA +HA × C + H), and the interaction between diet and açaí (C ×Table 2 – Initial body weight, body weight gain, liver weight, fe
diets
Measurements Experimenta
C CA
Initial body weight initial (g) a 139.4 ± 11.9 138.6 ± 11.3 1
Body weight gain (g) a 55.66 ± 7.12 55.85 ± 7.36 6
Liver weight (g) a 5.82 ± 0.50 5.60 ± 0.43 8
Fecal excretion (g/d) ab 0.58 ± 0.07 0.83 ± 0.11 0
Food intake (g/d) b c 14.29/13.39-14.61A 13.92/13.57-13.97A 1
a Values are expressed as means ± SD (n = 8 per group). The data were t
b Daily per animal (in grams per day).
c Data submitted to the nonparametric Kruskal-Wallis test and Dunn po
superscript letters (A-B) (P < .05). Values are expressed as the median/intCA × H × HA). The Bonferroni t test was used for multiple
comparisons among themeans. Data that did not fit the normal
distribution were analyzed using a Kruskal-Wallis nonpara-
metric test and Dunn posttest. The differences were considered
statistically significantwhen P < .05. For the remaining analyses
(Fig.), Student unpaired t test was used. The results are
expressed as means and SDs or as medians and interquartile
ranges. The minimum sample size needed to detect a
statistically significant difference (P < .05) was calculated
based on the power of 0.9 (G*Power 3.13, statistical power
analyses program; http://www.psycho.uni-deusselforf.de/aap).
Statistical analyses were performed using GraphPad Prism
version 4.00 for Windows (GraphPad, San Diego, CA, USA).3. Results
3.1. Body weight gain, liver weight, fecal excretion, and
food intake
We first examined how the addition of açaí pulp in the diet
affected body weight gain, liver weight, fecal excretion, and
food intake. The data in Table 2 indicate that hypercholester-
olemic rats exhibited an increase in weight gain and liver
weight. The addition of 2% açaí pulp to the diets did not affect
these parameters. The rats of the H group ingested less food
and excreted a lower amount of feces compared with the
controls. The addition of 2% açaí pulp did not affect the food
intake of the animals fed the standard diet, but it significantly
increased the intake of the animals fed the hypercholesterol-
emic diet. The açaí supplementation significantly increased
the fecal excretion of the rats in both the control and the
hypercholesterolemic groups (Table 2).
3.2. Cholesterol analysis in serum
To assess the effectiveness of the diet for promoting
hypercholesterolemia and to determine the effects of the
treatment with açaí, we measured the serum TC of the
animals at the beginning of the experiment, after 14 days of
adaptation to the control and hypercholesterolemic diets, and
at the end of the experimental period (56 days). No difference
in the TC levels was found at the beginning of the experimentcal excretion, and food intake of rats fed the experimental
l groups ANOVA (P value)
H HA Diet Açaí Açaí × Diet
39.3 ± 11.1 138.9 ± 13.7 .9884 .8846 .9653
4.81 ± 12.8 66.94 ± 6.59 .0031 .7141 .7588
.87 ± 0.62 9.31 ± 0.96 <.0001 .6537 .1685
.55 ± 0.07 0.69 ± 0.10 .016 <.0001 .1051
0.62/10.28-10.72B 13.11/12.79-14.13A – – –
ested using 2-way ANOVA (P < .05).
sttest; significantly different values are marked with different
erquartile ranges (n = 8 per group).
Table 3 – Initial TC, TC with 14 days of adaptation, and final TC of rats fed the experimental diets
Measurements Experimental groups ANOVA (value of P)
C CA H HA Diet Açaí Açaí × Diet
Initial TC (mmol/L) a 1.68 ± 0.26 1.81 ± 0.25 1.78 ± 0.18 1.74 ± 0.27 .8644 .6091 .3165
TC 14 days (mmol/L) a 2.32 ± 0.35 2.48 ± 0.17 3.79 ± 1.66 3.58 ± 2.04 .0107 .9583 .7025
Final TC (mmol/L) a 2.20 ± 0.16C 2.24 ± 0.16C 4.24 ± 1.08A 3.25 ± 0.69B <.0001 .0497 .0353
a Values are expressed as means ± SD (n = 8 per group). The data were tested using 2-way ANOVA. The Bonferroni t test was used for multiple
comparisons among the means. Within a row, significantly different values are marked with different superscript letters (A-C) when a
significant interaction was observed (P < .05).
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hypercholesterolemic rats (H and HA) were 1.6-fold higher
than those of the control animals (C and CA). At the end of the
experiment, the rats of the H group maintained higher levels
of TC than the control rats, and the addition of 2% açaí pulp to
the hypercholesterolemic diet (HA group) significantly re-
duced their TC values (Table 3).
3.3. Serum lipids, atherogenic index, and cholesterol in
the feces
As expected, the animals fed the hypercholesterolemic diet
exhibited increased levels of non–HDL-C, increased fecal
cholesterol excretion, decreased levels of HDL-C, and a higher
atherogenic index relative to the control group (Table 4). The
açaí supplementation significantly increased HDL-C levels
and reduced the levels of non–HDL-C in the CA and HA group
rats. The addition of 2% açaí pulp to the hypercholesterolemic
diet (HA group) promoted a 31% reduction in the atherogenic
index and a 44% increase in the fecal cholesterol excretion in
comparison with the H group (Table 4).
3.4. Cholesterol metabolism gene messenger
RNA expression
To investigate the molecular mechanisms involved in the
hypocholesterolemic effect of açaí pulp, the expression of the
genes involved in cholesterol homeostasis was evaluated by
quantitative transcriptase PCR, including SREBP-2, HMG CoA-
R, LDL-R, ApoB100, ABCG5, ABCG8, and CYP7A1. As shown in
Fig., the H group presented a reduction in the expression of
theSREBP-2, HMG CoA-R, and LDL-R genes, relative to the
controls. These genes are involved in hepatic cholesterolTable 4 – Serum lipids, atherogenic index, and cholesterol in th
Measurements Experimenta
C CA
HDL-C (mmol/L) a 1.49 ± 0.14 1.66 ± 0.18
Non–HDL-C (mmol/L) a 0.71 ± 0.20 0.57 ± 0.28
Atherogenic indexab 0.48 ± 0.16C 0.36 ± 0.21c 3
TC feces (mg cholesterol/g feces) a 1.61 ± 0.67C 1.10 ± 0.50C
a Values are expressed as means ± SD (n = 8 per group). The data were te
comparisons among the means. Within a row, significantly different
significant interaction was observed (P < .05).
b Atherogenic index = (TC − HDL-C) × (HDL-C)−1.biosynthesis. The HA group exhibited 1.3- and 2.2-fold in-
creases in the expression of LDL-R and SREBP-2, respectively,
relative to the H group. The expression of HMG CoA-R was
unaffected by açaí supplementation.
The H group presented an increase in ApoB100 and a
decrease in CYP7A1 expression compared with the C group.
The messenger RNA (mRNA) levels for CYP7A1 in the
hypercholesterolemic rats that received the açaí supplemen-
tation (HA group) did not differ from those in the H group, but
the ApoB100 expression was significantly lower in these
animals (HA group) than in the H group. The addition of 2%
açaí pulp to the hypercholesterolemic diet (HA group)
increased the mRNA levels of ABCG5 and ABCG8 compared
with the mRNA levels of the genes in the H group (Fig.).4. Discussion
Owing to the public interest in the prevention and/or treatment
of cardiovascular disease and other metabolic diseases, exten-
sive studies have been conducted to identify natural products
that can regulate dyslipidemia. Increasing evidence suggests
that the various components of açaí contribute to cardioprotec-
tion via mechanisms that affect cell membrane receptors,
intracellular signaling pathway proteins, and themodulation of
gene expression [37-41]. It has been demonstrated that flavo-
noids regulate the activity of the nuclear receptor regulators of
cellular lipid metabolism [42,43].
The present study was designed to investigate the hypo-
cholesterolemic activity of açaí pulp using a rat model of
dietary-induced hypercholesterolemia. A 2% açaí pulp dose
was chosen because of its relevance to human nutrition. This
dosage mimics the addition of a portion of this fruit in foode feces of rats fed the experimental diets
l groups ANOVA (value of P)
H HA Diet Açaí Açaí × Diet
0.13 ± 0.01 0.15 ± 0.02 <.0001 .0259 .0638
4.11 ± 1.08 3.10 ± 0.71 <.0001 .0232 .0802
1.19 ± 9.13A 21.56 ± 8.26B <.0001 .0332 .0377
9.14 ± 2.09B 16.16 ± 6.6A <.0001 .0138 .0051
sted using 2-way ANOVA. The Bonferroni t test was used for multiple
values are marked with different superscript letters (A-C) when a
Fig. – Effect of açaí supplementation on themRNA expression of genes involved in cholesterol metabolism in the rat. Rats were
fed the following diets: C, CA, H, and HA groups. SREBP-2 (A), HMG CoA-R (B), LDL-R (C), ApoB100 (D), ABCG5 (E), ABCG8 (F), and
CYP7A1 (G). Values are expressed as means ± SD (n = 6 per group). The data were tested using Student unpaired t test. *P < .05
with respect to the C group; **P < .01 with respect to the C group; ***P < .001 with respect to the C group; #P < .05 with respect to
the H group; ##P < .01 with respect to the H group; ###P < .001 with respect to the H group.
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[10,15,16]. Corroborating our previous results [15], açaí sup-
plementation improved the lipid profile in the rat. Thus, we
focused on characterizing the effects that açaí pulp supple-
mentation in the diet would have on the transcription of thegenes involved in cholesterol metabolism and fecal choles-
terol excretion.
The liver plays a key role in cholesterol homeostasis, and
the conversion of cholesterol to bile acids is a major pathway
of cholesterol catabolism. The present study demonstrated
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expression of CYP7A1. These results are in agreement with
other studies [45,46]; however, açaí supplementation had no
effect on CYP7A1. The activity of CYP7A1 can have a major
impact on the overall catabolism of excess cholesterol, but
other metabolic processes favor cholesterol elimination from
the body, such as cholesterol secretion into the bile via the
ABCG5 and ABCG8 transporters [47,48]. The addition of açaí
pulp to the hypercholesterolemic diet up-regulated the
expression of the ABCG5/G8 transporters. These transporters
are expressed, almost exclusively, in the liver and intestine
and mandatorily form a functional heterodimer that acts as a
transporter for cholesterol efflux [49]. ATP-binding cassette,
subfamily G transporters 5 and 8 transgenic mice that were
overexpressing the transgene in the liver and the intestine
were crossed into the atherosclerotic LDL-R−/− genetic back-
ground, and these mice developed significantly less athero-
sclerosis than the wild-type controls [50]. Yu et al [25]
demonstrated that increased expression of ABCG5 and
ABCG8 in the liver and small intestine in mice causes
profound alterations in cholesterol trafficking, which is
characterized by an increase in the biliary cholesterol
secretion and a reduction in cholesterol absorption. Diet
supplementation with açaí pulp increased the mRNA levels
of the ABCG5/G8 transporters in hypercholesterolemic rats.
Up-regulation of the transporters is the likely mechanism
underlying the decreased concentration of serum cholesterol
and increased fecal cholesterol excretion.
The hepatic cholesterol metabolism associated with the
concentrations of plasma and intracellular cholesterol is
mainly regulated by SREBP-2, a nuclear transcription factor
that binds to the membranes of the endoplasmic reticulum.
Sterol regulatory element–binding protein-2 is regulated both
at the transcriptional level by sterol depletion and at the
posttranslational level by a proteolytic cleavage cascade [19].
The hypercholesterolemic rats exhibited a lower expression of
SREBP-2, suggesting that a hypercholesterolemic diet would
lead to a saturated cholesterol state in hepatocytes and
resulting in a down-regulation of the de novo synthesis of
cholesterol with a decline in SREBP-2 expression. In addition,
the açaí pulp decreased the cholesterol concentration, which,
in turn, up-regulated the expression of SREBP-2.
In cells deprived of cholesterol, SREBP-2 binds and
activates the promoters of LDL-R and HMG CoA-R genes.
Increased hepatic LDL-R expression results in an improved
clearance of plasma LDL-C, which has been strongly
associated with a decreased risk of the development of
cardiovascular disease in humans [51]. Because the LDL-R is
also regulated by the intracellular concentrations of choles-
terol, the hypercholesterolemic diet and the açaí pulp
affected the expression of this receptor in response to
SREBP-2 similarly, suggesting a possible mechanism of
action of açaí in the reduction of serum non–HDL-C and,
therefore, of TC. Similar to the regulation of LDL-R,
cholesterol concentrations modulate the expression and
activity of HMG CoA-R. The results of other studies indicate
that expression of the HMG CoA-R gene in the liver of rats
on a high lipid diet is slightly down-regulated compared
with that of the control rats, which is similar to the results
found in this study [20,52,53].Apolipoprotein B100 is associated with hepatic-derived
non–HDL-C and is incorporated into the nascent lipoprotein
particles, along with cholesterol and triglycerides [54]. Owing
to the positive effects of açaí in reducing the levels of non–
HDL-C and the fact that polyphenols affect apolipoprotein B
secretion rates [55,56], we decided to evaluate the gene
expression of this apolipoprotein. Açaí supplementation de-
creases the mRNA levels of ApoB100, suggesting that the
reduction in the overall secretion of the VLDL is caused by
modifications in the packaging of this lipoprotein.
In conclusion, the present study is the first to study the
effect of açaí on cholesterol balance. Our results provide insight
into the molecular mechanisms involved in the cholesterol-
lowering properties of açaí. However, our study is limited in
that only the gene profile was analyzed; thus, it is important to
confirm if alterations of genes expression are reflected by
protein levels. Based on these results, we accept our hypothesis
that açaí pulp exerts a hypocholesterolemic effect by inducing
differential gene expression in the rat. The hypocholesterole-
mic effect observed in the rats fed açaí pulp can primarily be
attributed to the enhanced expression of the ABCG5 andABCG8
transporters. These alterations directly increased the rate of
biliary sterol excretion and increased uptake of LDL cholesterol
by the liver via the up-regulation of LDL-R.Acknowledgment
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